Designed as a journal of conservative opinion. Covers the national and international developments related to conservative action and reports and analyzes on what various conservatives are saying, thinking and doing. Committed to providing important, expert analyses of the day’s hottest stories and to breaking those stories in a manner consistent with the publication's worldview.

Re-launched on April 18, 2011, previously three separate print publications, Adweek, Mediaweek and Brandweek. Edited for executives in the advertising, marketing, sales promotion and merchandising industries. Originally established in 1979 and provides inside stories on creativity, client/agency relationships and successful global advertising strategies. Features news of accounts in review, excellence in creative work, new campaigns and account opportunities. Delivers national, global and local information about the advertising industry in the U.S. Adweek DOES accept bylined articles/submissions for the Voice section. Contact the Editorial Director and Managing Editor. This publication offers paid placements and commercial content opportunities.

Industry Dive is a Business news publication that takes a deep dive into 16 of the most competitive industries. Industries included on website: BioPharma, CIO, Construction, Education, Food, Grocery, HR, Healthcare, Marketing, MedTech, Restaurant, Retail, Smart Cities, Supply Chain, Utility, and Waste.

Background and Format The Thomson Reuters Foundation, the charitable arm of Thomson Reuters, covers the world’s under-reported stories, with a global team of about 40 staff journalists on humanitarian crises, women’s empowerment, the human impact of climate change, property rights, and trafficking and slavery. All of its stories are published on its news website, news.trust.org, as well as distributed on the Reuters news wire.

Pink Sheet is a website delivering insights and lessons learned that biopharma leaders need to inform their decision making and strategic planning from a policy and regulatory perspective, keep themselves and their companies out of trouble and in compliance, and get their products approved. More than just news, Pink Sheet provides analysis, and commentary focused on regulatory implications, including high value perspectives from insiders and thought leaders across the globe – giving regulatory professionals an objective view of how to anticipate challenges, minimize risks, and maximize opportunities. From lessons learned, to why today’s headlines matter; from trends shaping the dynamics of the global pharmaceutical and biotech sectors; to the exclusive, proprietary data behind these trends and more.